N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
- Citation:
- Ann Oncol vol 21 (3) 493-7
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W W Tan D W Hillman M Salim D W Northfelt D M Anderson P J Stella R Niedringhaus A M Bernath S S Gamini F Palmieri E A Perez
- Networks:
- Study
- NCCTG-0332
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: